Historique
Article de Périodique
From Hofmann to the Haight Ashbury, and into the future: The past and potential of lysergic acid diethlyamide (2014)
Auteur(s) :
SMITH, D. E. ;
RASWYCK, G. E. ;
DICKERSON DAVIDSON, L.
Année
2014
Page(s) :
3-10
Sous-type de document :
Revue de la littérature / Literature review
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
ETATS-UNIS
Thésaurus mots-clés
LSD
;
RECHERCHE
;
USAGE THERAPEUTIQUE
;
HALLUCINOGENES
;
HISTOIRE
Résumé :
Since the discovery of its psychedelic properties in 1943, lysergic acid diethylamide (LSD) has been explored by psychiatric/therapeutic researchers, military/intelligence agencies, and a significant portion of the general population. Promising early research was halted by LSD's placement as a Schedule I drug in the early 1970s. The U.S. Army and CIA dropped their research after finding it unreliable for their purposes. NSDUH estimates that more than 22 million (9.1% of the population) have used LSD at least once in their lives. Recently, researchers have been investigating the therapeutic use of LSD and other psychedelics for end-of-life anxiety, post-traumatic stress disorder (PTSD), cancer, and addiction treatment. Adverse psychedelic reactions can be managed using talkdown techniques developed and in use since the 1960s.
Affiliation :
David E. Smith, M.D. & Associates, San Francisco, CA, USA
Cote :
Abonnement